ZURA BIO LIMITED Investment Income, Dividend
ZURA BIO LIMITED (ZURA) reported Investment Income, Dividend of $1.39 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-25.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeDividend · last filed 2025-03-25
- ZURA BIO LIMITED investment income, dividend for the quarter ending 2023-12-31 was $0.00.
- ZURA BIO LIMITED investment income, dividend for the quarter ending 2023-09-30 was $987.00K.
- ZURA BIO LIMITED investment income, dividend for the quarter ending 2023-06-30 was $405.00K.
- ZURA BIO LIMITED investment income, dividend for fiscal 2023 was $1.39M.
| Period end | Investment Income, Dividend 3 month | Investment Income, Dividend 6 month | Investment Income, Dividend 9 month | Investment Income, Dividend 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $987.00K derived: sum of 2 quarters · filed 2025-03-25 | $1.39M derived: sum of 3 quarters · filed 2025-03-25 | $1.39M 10-K · filed 2025-03-25 |
| 2023-09-30 | $987.00K 10-Q · filed 2024-11-07 | $1.39M derived: sum of 2 quarters · filed 2024-11-07 | $1.39M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $405.00K 10-Q · filed 2024-08-13 | $405.00K 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |